Highlights:
The U.S. market for fertility clinic services is estimated to increase from $8.9 billion in 2023 to reach $16.8 billion by 2028, at a compound annual growth rate (CAGR) of 13.6% from 2023 through 2028.
The assisted reproductive technology (ART) segment of the U.S. fertility clinic services market is estimated to increase from $7.1 billion in 2023 to reach $13.7 billion by 2028, at a CAGR of 14.2% from 2023 through 2028.
The diagnostic services segment of the U.S. fertility clinic services market is estimated to increase from $1.3 billion in 2023 to reach $2.3 billion by 2028, at a CAGR of 12.0% from 2023 through 2028.
Report Scope:
The scope of this report is broad and covers emerging trends in the U.S. fertility clinic market. No other geographic regions are covered. This report segments the U.S. fertility clinic market into assisted reproductive technology, diagnostic services and surgeries.
This report highlights the current and future market potential and provides a detailed analysis of the market's drivers, challenges and opportunities. For market estimates, data has been provided for 2020, 2021 and 2022 (as the base year), along with a forecast for 2028. The report also analyzes the market shares of leading companies and includes profiles of the major players in the market. It also analyzes the impact of the COVID-19 pandemic on the U.S. fertility clinic market.
Report Includes:
- 37 tables
- An up-to-date overview and analysis of the U.S. market for fertility clinic services
- Analyses of the regional market trends, with historical market revenue data (sales figures) for 2020-2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussion of the major growth drivers, industry-specific challenges, technology advancements, and the U.S. regulations and policies for fertility clinic services, which will shape the market as a basis for projecting demand in the next few years (2023-2028)
- Estimation of the actual market size and revenue forecast for the U.S. fertility clinics market, and corresponding market share analysis based on the type of service and end-user
- Discussion on cause of infertility and stages of fertility treatment along with the improved safety and efficacy of assisted reproductive technology
- Examination of the critical market characteristics of the fertility market, including technological developments, the value chain, market dynamics, and key market trends
- Insight into the recent structure of the industry, regulatory aspects, increasing investment on R&D activities, market development strategies, and company value share analysis
- Profile descriptions of the major fertility clinics corporations, including Boston IVF LLC, CNY Fertility Center, NYU Langone Fertility Center, Shady Grove Fertility (SGF), Weill Cornell Medicine, and the UCSF Center for Reproductive Health (CRH)
Table of Contents
Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing the Study
- Scope of Report
- Information Sources
- Research Methodology
- What's New in this Update?
- Analyst's Credentials
- BCC Custom Research
- Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market Outlook
Chapter 4 Market Overview
- Introduction
- Service Definition
- Services and Treatments
- Causes of Infertility
- Diagnosis Services
- Stages of Fertility Treatment
- Key Participants in the Market Value Chain
Chapter 5 Emerging Trends in the U.S. Fertility Clinic Market
- Overview
- Advances in Reproductive Technologies
- Artificial Intelligence
- Stem Cell Treatment
- Cryopreservation
- Intervaginal Culture Devices
- Laser-Assisted Hatching
- Ovarian Platelet-Rich Plasma Treatment
- Preimplantation Genetic Testing
- Growing Focus on LGBTQ+ Family Building
- Increasing Emphasis on Patient-Centric Care
- Expanding Insurance Coverage
- Internet and Fertility
Chapter 6 Market Dynamics
- Introduction
- Market Drivers
- Age and Infertility
- Single Mothers
- Obesity
- Cultural Shifts
- LGBTQ Community
- Reimbursement and Benefits
- Market Challenges
- Lack of Insurance Coverage
- Legal and Ethical Dilemmas
- Risks Related to ART
- Economic Barriers
- Market Opportunities
- Increase Access to Infertility Care
- Medical Tourism
- COVID-19's Impact on the U.S. Fertility Clinics Market
Chapter 7 U.S. Fertility Clinics Market by Type
- Introduction
- Market Revenue
- ART Procedures
- Market Revenue
- Diagnostic Services
- Surgeries
Chapter 8 U.S. Market for Fertility Drugs
- Introduction
- Market Revenue
Chapter 9 U.S. Fertility Clinics Market by End User
- Introduction
- Market Revenue
Chapter 10 Regulatory Aspects
- Introduction
- Regulations Regarding IVF in the U.S.
- Regulations Regarding IUI in the U.S.
- Regulations Regarding Surrogacy in the U.S.
- Regulations Regarding Egg Freezing in the U.S.
- Regulations Regarding Sperm Donation in the U.S.
Chapter 11 Competitive Landscape
- Mergers and Acquisitions (M&A) and Collaborations
- Company Market Share by Number of Cycles Performed in 2021
Chapter 12 Company Profiles
- BOSTON IVF LLC
- BRIGHAM AND WOMEN'S HOSPITAL
- CNY FERTILITY CENTER
- FERTILITY CENTER OF ILLINOIS
- MASSACHUSETTS GENERAL HOSPITAL FERTILITY CENTER
- MAYO CLINIC ASSISTED REPRODUCTIVE TECHNOLOGIES
- NEW HOPE FERTILITY CENTER
- NYU LANGONE FERTILITY CENTER
- REPRODUCTIVE MEDICINE ASSOCIATES OF NEW JERSEY
- SHADY GROVE FERTILITY-ROCKVILLE
- UCSF CENTER FOR REPRODUCTIVE HEALTH